BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang YQ, Pan D, Yao ZY, Li YQ, Qu PF, Wang RB, Gu QH, Jiang J, Han ZX, Liu HN. Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy. World J Gastroenterol 2024; 30(37): 4132-4148 [PMID: 39474397 DOI: 10.3748/wjg.v30.i37.4132]
URL: https://www.wjgnet.com/1948-5204/full/v30/i37/4132.htm
Number Citing Articles
1
Miho Akabane, Jun Kawashima, Abdullah Altaf, Selamawit Woldesenbet, François Cauchy, Federico Aucejo, Irinel Popescu, Minoru Kitago, Guillaume Martel, Francesca Ratti, Luca Aldrighetti, George A. Poultsides, Yuki Imaoka, Andrea Ruzzenente, Itaru Endo, Ana Gleisner, Hugo P. Marques, Sara Oliveira, Jorge Balaia, Vincent Lam, Tom Hugh, Nazim Bhimani, Feng Shen, Timothy M. Pawlik. Unraveling the Obesity Paradox in Hepatocellular Carcinoma: Relative Role of Elevated Body Mass Index on Detrimental Effects of Postoperative ComplicationsHPB 2025;  doi: 10.1016/j.hpb.2025.05.005
2
Leandro Sierra, Mohamad-Noor Abu-Hammour, Arjun Chatterjee, C Roberto Simons-Linares. Obesity paradox role in the immunosuppressive treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2025; 31(19): 105617 doi: 10.3748/wjg.v31.i19.105617
3
Camrelizumab/lenvatinibReactions Weekly 2024; 2035(1): 126 doi: 10.1007/s40278-024-70876-8
4
Yun Feng, Bingran Yu, Anxiao Liu, Chongpeng Cai, Changming Zhou, Tong Tong, Lu Wang, Qi Pan. Prognostic impact of body composition in hepatocellular carcinoma patients undergoing interventional and systemic therapyFrontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1586202